Temporary source issue: live-price. Available sections remain usable while the affected layer retries on a later request.
Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Reported and computed values remain separate; missing values are not converted to zero.
Research path: Interpret Paushak's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
Calculated from validated daily candles. Descriptive research only.
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 659.94 | 571.98 | 481.35 |
| Accumulated Depreciation Total | -89.48 | -68.53 | -53.6 |
| Other Liabilities Total | 5.23 | 5.14 | 3.12 |
| Long Term Debt | 60 | 25 | Not available |
| Common Stock Total | 12.33 | 3.08 | 3.08 |
| Other Equity Total | 95.16 | 102.72 | 88.4 |
| Other Current Assets Total | 12.22 | 14.32 | 0.49 |
| Total Assets | 659.94 | 571.98 | 481.35 |
| Cash | 0.02 | 0.01 | 0.62 |
| Total Equity | 491.12 | 465.49 | 408.12 |
| Long Term Investments | 125.27 | 134.31 | 83.4 |
| Retained Earnings(Accumulated Deficit) | 383.63 | 359.68 | 316.64 |
| Total Common Shares Outstanding | 2.47 | 2.47 | 2.47 |
| Property/Plant/Equipment Total-Gross | 492.28 | 399.4 | 234.64 |
| Tangible Book Valueper Share Common Eq | 199.17 | 188.77 | 165.5 |
| Total Liabilities | 168.82 | 106.49 | 73.22 |
| Total Debt | 76.94 | 25.01 | 0 |
| Short Term Investments | 27.35 | 8.52 | 141.35 |
| Cashand Short Term Investments | 27.36 | 8.54 | 141.98 |
| Total Receivables Net | 55.44 | 55.09 | 51.04 |
| Notes Payable/Short Term Debt | 16.94 | 0.01 | 0 |
| Deferred Income Tax | 38.15 | 31.91 | 44.14 |
| Accounts Receivable-Trade Net | 54.86 | 54.52 | 50.68 |
| Property/Plant/Equipment Total-Net | 402.8 | 330.87 | 181.04 |
| Total Current Liabilities | 65.44 | 44.44 | 25.97 |
| Total Inventory | 36.64 | 21.64 | 21.77 |
| Accounts Payable | 30.67 | 20.15 | 15.91 |
| Other Currentliabilities Total | 17.84 | 24.28 | 10.05 |
| Total Long Term Debt | 60 | 25 | 0 |
| Intangibles Net | 0.04 | 0.05 | 0.05 |
| Other Long Term Assets Total | 0 | Not available | Not available |
| Note Receivable-Long Term | 0.18 | 7.17 | 1.33 |
| Total Current Assets | 131.66 | 99.58 | 215.53 |
| Prepaid Expenses | Not available | Not available | 0.25 |
Operating Margin 12m18.03
Operating Margin 5y Avg24.33
Net Profit Margin 12m17.98
Net Profit Margin 5y23.51
Dividend Yield %0.44
Price to Sale Ratio6.16
Overall RiskHigh risk
Board Risk52.57
Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Asian Paints | INR 2,666 | 2.56 L | 58.14 | — |
| Solar Industries India | INR 18,906.05 | 1.71 L | 102.64 | — |
| Pidilite Industries | INR 1,579.8 | 1.61 L | 64.75 | — |
| SRF | INR 2,865.15 | 85,172.05 | 44.53 | — |
| Linde India | INR 6,897.45 | 58,824.36 | 108.69 | — |
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Paushak Ltd files BRSR for FY26, reports zero safety incidents scanx.trade
Paushak Limited to hold AGM on July 30, 2026 scanx.trade
Paushak Q4 Results 2026 - Find Paushak Q4 Earnings Result | PAUSHAKLTD Q4 results Mint
Paushak Ltd Balance Sheets, Financial Statements The Economic Times
Paushak Limited announces Annual dividend, payable on August 29, 2026 marketscreener.com
Paushak Ltd is Rated Sell Markets Mojo
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.
Paushak Limited is an India-based company, which is engaged in the business of specialty chemicals. The Company is engaged in the business of manufacturing phosgene-based specialty chemicals. Its product categories include chloroformate, isocyanate, chloride, carbonate/carbamate, and others. Its chloroformate products include benzyl chloroformate, ethyl chloroformate, methyl chloroformate, and myristyl chloroformate. The Company's isocyanate products include 2-chloro ethyl isocyanate, phenyl isocyanate, and stearyl isocyanate. Its chloride products include 3 chloropropionyl chloride, diethyl carbamoyl chloride, and dimethyl carbamoyl chloride. The Company's carbonate/carbamate products include polyquaternium, chloromethyl isopropyl carbonate, and bis-(4 nitrophenyl) carbonate. Its other products include tetrabutyl urea, vilsmeier reagent, and dicyclohexyl carbodiimide. It serves various industries, such as pharmaceuticals, agrochemicals, performance, and custom synthesis.
Paushak has the symbol PAUSHAKLTD and ISIN - INE111F01024.
Paushak is currently trading at INR 705.00.
Paushak has a year high of INR 826.75 and a year low of INR 342.50.
Paushak has a market capitalization of INR 1,345.49 crore.
Paushak has a P/E ratio of 21.64.
Paushak has a dividend yield of 0.44%.
Paushak has revenue of INR 218.60 crore, net income of INR 39.33 crore, and EPS of INR 15.94.
Paushak has a book value of INR 199.17.
Paushak has a debt-to-equity ratio of NA.
Paushak has a price-to-book ratio of 3.54 and a price-to-sales ratio of 6.16.
Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.